ArticleFrontiers in immunology2026
Immune checkpoint inhibitor-related thyroid dysfunction during treatment of lung cancer: a disproportionality analysis based on the FDA adverse event reporting system.
Yaqian Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.